• Demystifying biologics, their biosimilars and the PBS

  • 2021/05/18
  • 再生時間: 20 分
  • ポッドキャスト

Demystifying biologics, their biosimilars and the PBS

  • サマリー

  • In this episode, Professor Debra Rowett is joined by Professor Andrew Wilson, Chair of the Pharmaceutical Benefits Advisory Committee and Dr Paul Kubler, Consultant Rheumatologist to discuss how b/tsDMARDs are funded in Australia, the policies and mechanisms that influence the cost to government and how the introduction of biosimilars affects the pricing of biologics on the PBS. 

    続きを読む 一部表示

あらすじ・解説

In this episode, Professor Debra Rowett is joined by Professor Andrew Wilson, Chair of the Pharmaceutical Benefits Advisory Committee and Dr Paul Kubler, Consultant Rheumatologist to discuss how b/tsDMARDs are funded in Australia, the policies and mechanisms that influence the cost to government and how the introduction of biosimilars affects the pricing of biologics on the PBS. 

activate_buybox_copy_target_t1

Demystifying biologics, their biosimilars and the PBSに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。